Retrospective observational analysis of ferric pyrophosphate citrate (triferic®) administered via dialysate. Experience at a single facility over 2 years
<p>Background: Ferric pyrophosphate citrate (FPC, Triferic®) is a unique form of iron therapy that is indicated to maintain iron balance and hemoglobin concentration in adult hemodialysis patients. We conducted an analysis of observational data from an independent dialysis facility that has ad...
Bewaard in:
Hoofdauteurs: | Marc Hoffman (Auteur), Richard Delvalle (Auteur), Raymond D Pratt (Auteur) |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Archives of Clinical Nephrology - Peertechz Publications,
2021-06-17.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
door: T. Christopher Bond, et al.
Gepubliceerd in: (2012) -
Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
door: Eun ji Park, et al.
Gepubliceerd in: (2019) -
Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
door: Ajay Gupta
Gepubliceerd in: (2014) -
Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
door: Xueying Ding, et al.
Gepubliceerd in: (2024) -
Pseudogout and Calcium Pyrophosphate Disease
door: Andrew Williamson
Gepubliceerd in: (2017)